欢迎来到《四川大学学报(医学版)》
何朗, 孙永红, 刘康等. Rh-Endostatin作用肺癌血管正常化时相与CA9表达的关系初探[J]. 四川大学学报(医学版), 2017, 48(3): 342-346.
引用本文: 何朗, 孙永红, 刘康等. Rh-Endostatin作用肺癌血管正常化时相与CA9表达的关系初探[J]. 四川大学学报(医学版), 2017, 48(3): 342-346.
HE Lang, SUN Yong-hong, LIU Kang. et al. Study on the Relationship Between Normalization of Tumor Microvessels and CA9 for Rh-Endostatin to Inhibit[J]. Journal of Sichuan University (Medical Sciences), 2017, 48(3): 342-346.
Citation: HE Lang, SUN Yong-hong, LIU Kang. et al. Study on the Relationship Between Normalization of Tumor Microvessels and CA9 for Rh-Endostatin to Inhibit[J]. Journal of Sichuan University (Medical Sciences), 2017, 48(3): 342-346.

Rh-Endostatin作用肺癌血管正常化时相与CA9表达的关系初探

Study on the Relationship Between Normalization of Tumor Microvessels and CA9 for Rh-Endostatin to Inhibit

  • 摘要: 目的初步探索重组人血管内皮抑素(rh-Endostatin,rh-ES)作用于肺癌的血管正常化时相与CA9的关系,以及CA9在肺癌中的表达水平。方法收集对数生长期的Lewis细胞,制成1×106 mL-1的单细胞悬液,注射入40只C57/BL6小鼠(0.2 mL/只),建立Lewis肺癌皮下移植瘤(LLC)模型,然后随机分成对照组和rh-ES组,各20只。rh-ES组小鼠腹腔注射rh-ES 5 mg/(kg·d),9 d,1次/d。对照组小鼠同时点腹腔注射生理盐水(NS) 0.2 mL/次。于治疗第2、4、6、9天,每组各处死5只小鼠。免疫组化检测肿瘤组织和癌旁组织中CA9表达,Real-time PCR及ELISA技术分别检测两组不同时间点肿瘤组织中CA9表达。结果C57/BL6小鼠成瘤率为100%。同时,对照组不同时间点CA9在肿瘤组织中表达均高于癌旁组织(P<0.05)。Real-time PCR及ELISA发现在LLC移植瘤模型中CA9基因和蛋白表达在rh-ES组给药后第4天和第6天(血管正常化时相)降低,与同组第2天、第9天比较,差异有统计学意义(P<0.05),与对照组第4天和第6天比较,差异有统计学意义(P<0.05)。结论CA9在肿瘤组织中高表达。rh-ES 可于血管正常化时间段内降低CA9表达,逆转Lewis肺癌乏氧。

     

    Abstract: Objective To explore the relationship between normalization of tumor microvessels and CA9 for rh-Endostatin to inhibit Lewis lung cancer (LLC) and the expression level of CA9 in LLC. Methods Lewis cells of logarithmic growth phase were collected and made into 1×106 mL-1 cell suspensions were prepared. The transplanted tumor model of LLC was established on C57/BL6 mice by injected 0.2 mL cell suspensions/mice into 40 C57/BL6 mice. 40 LLC mice were randomly divided into control group and rh-ES group (20 mice per group). Control group experienced treatment of intraperitoneal injection (ip) for 0.2 mL NS/d, while rh-ES group was treated for 5 mg rh-ES/(kg·d) from the first to the ninth day. The samples of 5 mice were obtained from day 2, day 4, day 6 and day 9 after treatment in control group or rh-ES group, respectively. CA9 was tested by IHC in LLC and paracancerous tissues and estimated by RT-PCR and ELISA in the each time point of both rh-ES group and control group, respectively. Results The transplanted tumor model of LLC on C57/BL6 mice was established successfully. The expression of CA9 decreased on day 4 and day 6 in rh-ES group estimated by RT-PCR and ELISA, which indicated some great significance when compared with day 2, day 9 in rh-ES group and day 4, day 6 in control group (P<0.05), and the expression of CA9 in day 2, day 4, day 6, day 9 tested by IHC was higher in

     

© 2017 《四川大学学报(医学版)》编辑部 版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回